Toward new avenues in the treatment of nonsuicidal self-injury

Journal of Pharmacy Practice

Volumn 24, Issue 5, 2011, Pages 472-477

  Bloom, Christopher M ^a   Holly, Shareen ^b  

^a PROVIDENCE COLLEGE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

animal models; neurochemical pathways; nonsuicidal self injury; pharmacological treatment; self injurious behaviors

Indexed keywords

MONOAMINE; NALTREXONE; OPIATE; PEMOLINE; SEROTONIN UPTAKE INHIBITOR;

ARTICLE; AUTOMUTILATION; CEREBROSPINAL FLUID; DRUG EFFICACY; HUMAN; NEUROBIOLOGY; NEUROCHEMISTRY; NOCICEPTION; NONHUMAN; NONSUICIDAL SELF INJURY; STRESS; TREND STUDY;

EID: 83455245784     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190011422877     Document Type: Article

References (51)

1. Favazza AR. Why patients mutilate themselves. Hosp Community Psychiatry. 1989 ; 40 (2). 137-145 (Pubitemid 19062725)
2. Nixon MK, Heath NL Introduction to Nonsuicidal Self-injury in Adolescents. Chapter 1. MK Nixon NL Heath, ed. New York, NY: Routledge Press ; 2009 :
3. Nock MK, Favazza AR Nonsuicidal Self-injury: Definition and Classification. MK Nock, ed. Chapter 1. Washington, DC: American Psychological Association ; 2009 :
4. Laye-Gindhu A, Schonert-Reichl KA. Nonsuicidal self-harm among community adoelscents: Understanding the "whats" and "whys" of self-harm. J Youth Adolescence. 2005 ; 34 (5). 445-457
5. Nixon MK, Cloutier PF, Agarwal S. Affect regulation and addictive aspects of repetitive self-injury in hospitalized adolescents. J Am Acad Child Adolesc Psychiatry. 2002 ; 41 (11). 1333-1341 (Pubitemid 38338025)
6. Luiselli JK Nonsuicidal Self-injury among People with Developmental Disabilities. MK Nock, ed. Chapter 9. Washington, DC: American Psychological Association ; 2009 :
7. Andover MS, Pepper CM, Ryabchenko KA, et al. Self-mutilation and symptoms of depression, anxiety, and borderline personality disorder. Suicide Life-Threat Behav. 2005 ; 35 (5). 581-591 (Pubitemid 41633383)
8. Evren C, Evren B. Self-mutilation in substance-dependent patients and relationship with childhood abuse and neglect, alexithymia and temperament and character dimensions of personality. Drug Alcohol Depend. 2005 ; 80 (1). 15-22 (Pubitemid 41266958)
9. Claes L, Vandereycken W, Vertommen H. Self-care versus self-harm: piercing, tattooing, and self-injuring in eating disorders. Eur Eat Disord Rev. 2005 ; 13 (1). 11-18 (Pubitemid 40514500)
10. Solano R, Fernandez-Aranda F, Aitken A, et al. Self-injurious behavior in people with eating disorders. Eur Eat Disord Rev. 2005 ; 13: 3-10 (Pubitemid 40514499)
11. Stein D, Lilenfield LRR, Wildman PC, et al. Attempted suicide and self-injury in patients diagnosed with eating disorders. Compr Psychiatry. 2004 ; 45 (6). 447-451 (Pubitemid 39446809)
12. Haavisto A, Sourander A, Multimaki P, et al. Factors associated with ideation and acts of deliberate self-harm among 18-year-old boys. A prospective 10-year follow up study. Soc Psychiatry Psychiatr Epidemiol. 2005 ; 40 (11). 912-921 (Pubitemid 41662421)
13. Ross S, Heath NL. A study of the frequency of self-mutilation in a community sample of adolescents. J Youth Adolescence. 2002 ; 31 (1). 67-77 (Pubitemid 37131007)
14. Heath NL, Schaub KM, Holly S, et al Self-Injury in Youth: The Essential Guide to Assessment and Intervention. Nixon MK Heath NL eds, ed. New York, NY: Routledge Press ; 2009 :
15. Kies SD, Devine DP. Self-injurious behaviour: a comparison of caffeine and pemoline models in rats. Pharmacol Biochem Behav. 2004 ; 79 (4). 587-598 (Pubitemid 39600599)
16. Sandman CA Psychopharmacologic Treatment of Nonsuicidal Self-injury. MK Nock, ed. Washington, DC: American Psychological Association ; 2009 :
17. Carr EG. The motivation of self-injurious behavior: a review of some hypotheses. Psychol Bull. 1977 ; 84 (4). 800-816
18. Nock MK, Prinstein MJ. A functional approach to the assessment of self-mutilative behaviour. J Consult Clin Psychol. 2004 ; 72 (5). 885-890 (Pubitemid 39299450)
19. Gratz K, Roemer L. Multidimensional assessment of emotional regulation and dysregulation: development, factor structure, and initial validation of the difficulties in emotion regulation scale. J Psychopathol Behav Assess. 2004 ; 26 (1). 41-54 (Pubitemid 38182213)
20. Klonsky ED. The functions of deliberate self-injury: a review of the empirical evidence. Clin Psychol Rev. 2007 ; 27 (2). 226-239 (Pubitemid 46123124)
21. Sher L, Stanley BH. The role of endogenous opiods in the pathophysiology of self-injurious and suicidal behavior. Arch Suicide Res. 2008 ; 12 (4). 299-308
22. Stanley B, Sher L, Wilson S, et al. Non-suicidal self-injurious behavior, endogenous opiods and monoamine neurotransmitters. J Affect Disord. 2010 ; 124 (1-2). 134-140
23. Butler RF, Finn DP. Stress-induced analgesia. Prog Neurobiol. 2009 ; 88 (3). 184-202
24. Lester LS, Fanselow MS. Exposure to a cat produces opiod analgesia in rats. Behav Neurosci. 1985 ; 99 (4). 756-759 (Pubitemid 15045748)
25. Feldman RS, Myer JS, Quenzer LF Principles of Neuropsychopharmacology. Sunderland, MA: Sinauer Associates, Inc, Publishers ; 1997: 909.
26. Akil H, Watson S, Young E. Endogenous opiods: biology and function. Annu Rev Neurosci. 1984 ; 7: 223-255
27. Chipkin RE, Latranyi MB, Iorio LC. Potentiation of stress-induced analgesia (SIA) by thiorphan and its block by naloxone. Life Sci. 1982 ; 31 (12-13). 1189-1192 (Pubitemid 13250197)
28. Kars H, Broekema W, Glaudemans-van Gelderen I, et al. Naltrexone attenuates self-injurious behavior in mentally retarded subjects. Biol Psychiatry. 1990 ; 27 (7). 741-746 (Pubitemid 20132242)
29. Russ MJ, Roth SD, Kakuma T, et al. Pain perception in self-injurious Borderline patients: naloxone effects. Biol Psychiatry. 1994 ; 35 (3). 207-209 (Pubitemid 24078487)
30. Symons FJ, Thompson A, Rodriguez MC. Self-injurious behavior and the efficacy of naltrexone treatment: a quantitative synthesis. Ment Retard Dev Disabil Res Rev. 2004 ; 10 (3). 193-200 (Pubitemid 40095894)
31. Bodnar RJ, Merrigan KP, Sperger E. Potentiation of cold-water swim analgesia and hypothermia by clonidine. Pharmacol Biochem Behav. 1983 ; 19 (3). 447-451 (Pubitemid 13016743)
32. Nunes-de Souza RL, Canto-de-Souza A, da-Costa M, et al. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology. 2000 ; 150 (3). 300-310 (Pubitemid 30447850)
33. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?. Arch Gen Psychiatry. 1976 ; 33 (10). 1193-1197
34. Linnoila M, Virkkunen M, Scheinin M, et al. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983 ; 33 (26). 2609-2614 (Pubitemid 14203851)
35. Kruesi M, Rapoport K, Hamberger S, et al. Cerebrospinal fluid metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch Gen Psychiatry. 1990 ; 47 (5). 459-462
36. Higley JD, Mehlman PT, Taub DM, et al. Cerebrospinal fluid monoamine and adrenal correlates of aggression in free-ranging rhesus monkeys. Arch Gen Psychiatry. 1992 ; 49 (6). 436-441
37. Coccaro EM, Lee R, Kavoussi RJ. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology. 2010 ; 35 (2). 435-444
38. Bodfish JW, McCuller WR, Madison JM, et al. Placebo, double-blind evaluation of long-term naltrexone treatment effects for adults with mental retardation and self-injury. J Dev Phys Disabil. 1993 ; 2: 135-151
39. Bloch MR, Elliott M, Thompson H, et al. Fluoxetine in pathologic skin-picking. Psychosomatics. 2001 ; 42: 314-319
40. Sharma RC, Sharma NL. Effectiveness of fluoxetine in the treatment of skin-picking. Indian J Pscychiatry. 2005 ; 47 (4). 241-242 (Pubitemid 43291451)
41. Schepis C, Failla P, Siragusa M, et al. Failure of fluoxetine to modify the skin-picking behavior of Prader-Willi syndrome. Australas J Dermatol. 1998 ; 39 (1). 57-58 (Pubitemid 28217018)
42. Denys D, van Megen HG, Westenberg GM. Emerging skin-picking behaviour after serotonin reuptake inhibitor-treatment in patients with obsessive-compulsive disorder: possible mechanisms and implications for clinical care. J Psychopharmacology. 2003 ; 17 (1). 127-129 (Pubitemid 36373151)
43. Prinstein MJ. Introduction to the special section on suicide and nonsuicidal self-injury: a review of unique challenges and important directions for self-injury science. J Consult Clin Psychol. 2008 ; 76 (1). 1-8 (Pubitemid 351215322)
44. Genovese E, Napoli PA, Bolega-Zonta N. Self-aggressiveness: a new type of behavioral change induced by pemoline. Life Sci. 1969 ; 8 (9). 513-515
45. Muehlmann AM, Brown BD, Devine DP. Pemoline (2-Amino-5-phenyl-1, 3-oxazol-4-one)-induced self-injurious behavior: a rodent model of pharmacotherapeutic efficacy. J Pharmacol Exp Ther. 2008 ; 324 (1). 214-223 (Pubitemid 350294143)
46. Masi G. Pharmacotherapy of pervasive developmental disorders in children and adolescents. CNS Drugs. 2004 ; 18 (14). 1031-1052 (Pubitemid 39612012)
47. Lloyd KG, Hornykiewicz O, Davidson L, et al. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med. 1981 ; 305 (19). 1106-1111 (Pubitemid 11031666)
48. Saito Y, Ito M, Hanaoka C, et al. Dopamine receptor upregulation in Lesch-Nyhan syndrome: a postmortem study. Neuropediatrics. 1999 ; 30 (2). 66-71 (Pubitemid 29265402)
49. Muehlmann AM, Wilkinson JA, Devine DP. Individual differences in vulnerability for self-injurious behavior: studies using an animal model. Behav Brain Research. 2010 ; 217 (1). 148-54
50. Self-injurious behavior vs. non-suicidal self-injury: the CNS stimulant pemoline as a model of self-destructive behavior. Crisis: The Journal of Crisis Intervention and Suicide Prevention. 2011 :
51. Osuch EA, Payne GW Neurobiology of Nonsuicidal Self-injury. MK Nixon NL Heath, ed. New York: Routledge Press ; 2009 :